STOCK TITAN

atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

atai Life Sciences (Nasdaq: ATAI) will announce its Q3 2022 financial results and provide a business update on November 10, 2022. The announcement comes as atai continues its mission to innovate treatments for mental health disorders. A management interview will be accessible at 8:30 a.m. ET, providing insights into the company's progress and future outlook. Founded in 2018, atai is focused on developing therapeutics for depression, anxiety, and addiction.

Positive
  • None.
Negative
  • None.

NEW YORK and BERLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, plans to announce its third quarter 2022 financial results and business update on Thursday, November 10, 2022.

A video interview with atai management will be available at 8:30 a.m. (ET) at https://vimeo.com/atailifesciences. The archived video will be available in the “Events” section of the atai website at https://www.atai.life/.

About atai Life Sciences
atai Life Sciences is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Founded in 2018 as a response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to acquiring, incubating, and efficiently developing innovative therapeutics to treat depression, anxiety, addiction, and other mental health disorders. By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies to achieve clinically meaningful and sustained behavioral change in mental health patients.

atai's vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life

Contact Information

Investor Contact:
Stephen Bardin
Chief Financial Officer
Email: IR@atai.life

Media Contact:
Allan Malievsky
Senior Director of External Affairs
Email: PR@atai.life


FAQ

What are the financial results for atai Life Sciences for Q3 2022?

atai Life Sciences will announce its Q3 2022 financial results on November 10, 2022.

When will atai Life Sciences provide a business update?

atai Life Sciences will provide a business update on November 10, 2022.

What time will the management video interview be available for atai Life Sciences?

The video interview with atai management will be available at 8:30 a.m. ET on November 10, 2022.

Where can I watch the management interview of atai Life Sciences?

The management interview can be watched on the atai Life Sciences Vimeo page.

What is atai Life Sciences focused on developing?

atai Life Sciences is focused on developing therapeutic solutions for mental health disorders such as depression, anxiety, and addiction.

ATAI Life Sciences N.V. Common Shares

NASDAQ:ATAI

ATAI Rankings

ATAI Latest News

ATAI Stock Data

256.87M
151.01M
9.99%
26.83%
5.62%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BERLIN